| |
| |
|
| Insider
Information: |
Ali-Jackson Kamil |
| Relationship: |
|
| City: |
Malvern |
| State: |
PA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
240,728 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$258,024 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
240,728 |
|
|
| Total
Value |
$258,024 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Aclaris Therapeutics, Inc. |
ACRS |
Chief Legal Officer |
2022-01-03 |
160,214 |
|
0 |
Premium* |
|
|
PDS Biotechnology Corp |
PDSB |
|
2021-06-15 |
11,764 |
2021-06-15 |
0 |
Premium* |
|
|
Rigel Pharmaceuticals Inc |
RIGL |
|
2024-05-25 |
68,750 |
2022-05-20 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
64 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| RIGL |
Rigel Pharmaceuticals Inc |
|
• • – |
2024-05-25 |
4 |
A |
$0.00 |
$0 |
D/D |
25,000 |
68,750 |
0 |
- |
|
| ACRS |
Aclaris Therapeutics, Inc... |
Chief Legal Officer |
• – – |
2016-09-28 |
4 |
OE |
$0.72 |
$1,326 |
D/D |
1,841 |
77,798 |
0 |
- |
|
| ACRS |
Aclaris Therapeutics, Inc... |
Chief Legal Officer |
• – – |
2020-03-02 |
4 |
D |
$1.26 |
$6,022 |
D/D |
(4,779) |
99,199 |
0 |
- |
|
| ACRS |
Aclaris Therapeutics, Inc... |
Chief Legal Officer |
• – – |
2020-02-03 |
4 |
D |
$1.28 |
$1,687 |
D/D |
(1,318) |
86,803 |
0 |
- |
|
| ACRS |
Aclaris Therapeutics, Inc... |
Chief Legal Officer |
• – – |
2020-06-01 |
4 |
D |
$1.32 |
$12,585 |
D/D |
(9,534) |
122,853 |
0 |
- |
|
| ACRS |
Aclaris Therapeutics, Inc... |
Chief Legal Officer |
• – – |
2016-10-26 |
4 |
OE |
$1.52 |
$5,946 |
D/D |
3,912 |
79,869 |
0 |
- |
|
| ACRS |
Aclaris Therapeutics, Inc... |
Chief Legal Officer |
• – – |
2019-12-16 |
4 |
D |
$1.80 |
$895 |
D/D |
(497) |
83,448 |
0 |
- |
|
| ACRS |
Aclaris Therapeutics, Inc... |
Chief Legal Officer |
• – – |
2019-12-18 |
4 |
D |
$1.81 |
$501 |
D/D |
(277) |
84,246 |
0 |
- |
|
| ACRS |
Aclaris Therapeutics, Inc... |
Chief Legal Officer |
• – – |
2020-12-15 |
4 |
D |
$4.59 |
$2,286 |
D/D |
(498) |
124,089 |
0 |
- |
|
| ACRS |
Aclaris Therapeutics, Inc... |
Chief Legal Officer |
• – – |
2018-12-18 |
4 |
D |
$6.30 |
$1,928 |
D/D |
(306) |
79,645 |
0 |
- |
|
| ACRS |
Aclaris Therapeutics, Inc... |
Chief Legal Officer |
• – – |
2019-02-01 |
4 |
D |
$6.96 |
$9,104 |
D/D |
(1,308) |
82,212 |
0 |
- |
|
| ACRS |
Aclaris Therapeutics, Inc... |
Chief Legal Officer |
• – – |
2018-12-15 |
4 |
D |
$7.31 |
$3,604 |
D/D |
(493) |
78,876 |
0 |
- |
|
| PDSB |
PDS Biotechnology Corp |
|
• • – |
2021-06-15 |
4 |
B |
$8.50 |
$99,994 |
D/D |
11,764 |
11,764 |
0.01 |
- |
|
| ACRS |
Aclaris Therapeutics, Inc... |
Chief Legal Officer |
• – – |
2021-05-03 |
4 |
OE |
$10.66 |
$159,900 |
D/D |
15,000 |
158,618 |
0 |
- |
|
| ACRS |
Aclaris Therapeutics, Inc... |
Chief Legal Officer |
• – – |
2021-05-04 |
4 |
OE |
$10.66 |
$159,900 |
D/D |
15,000 |
158,618 |
0 |
- |
|
| ACRS |
Aclaris Therapeutics, Inc... |
Chief Legal Officer |
• – – |
2021-05-05 |
4 |
OE |
$10.66 |
$159,900 |
D/D |
15,000 |
158,618 |
0 |
- |
|
| ACRS |
Aclaris Therapeutics, Inc... |
Chief Legal Officer |
• – – |
2021-05-06 |
4 |
OE |
$10.66 |
$159,900 |
D/D |
15,000 |
158,618 |
0 |
- |
|
| ACRS |
Aclaris Therapeutics, Inc... |
Chief Legal Officer |
• – – |
2021-05-07 |
4 |
OE |
$10.66 |
$57,735 |
D/D |
5,416 |
149,034 |
0 |
- |
|
| ACRS |
Aclaris Therapeutics, Inc... |
Chief Legal Officer |
• – – |
2018-05-07 |
4 |
D |
$18.10 |
$35,729 |
D/D |
(1,974) |
92,636 |
0 |
- |
|
| ACRS |
Aclaris Therapeutics, Inc... |
Chief Legal Officer |
• – – |
2018-05-18 |
4 |
AS |
$20.00 |
$200,000 |
D/D |
(10,000) |
82,636 |
0 |
- |
|
| ACRS |
Aclaris Therapeutics, Inc... |
Chief Legal Officer |
• – – |
2018-06-11 |
4 |
AS |
$20.00 |
$2,000 |
D/D |
(100) |
82,536 |
0 |
- |
|
| ACRS |
Aclaris Therapeutics, Inc... |
Chief Legal Officer |
• – – |
2018-06-12 |
4 |
AS |
$20.00 |
$98,000 |
D/D |
(4,900) |
77,636 |
0 |
- |
|
| ACRS |
Aclaris Therapeutics, Inc... |
Chief Legal Officer |
• – – |
2016-08-26 |
4 |
AS |
$20.35 |
$76,068 |
D/D |
(3,738) |
20,289 |
0 |
- |
|
| ACRS |
Aclaris Therapeutics, Inc... |
Chief Legal Officer |
• – – |
2021-02-01 |
4 |
D |
$21.35 |
$28,139 |
D/D |
(1,318) |
126,646 |
0 |
- |
|
| ACRS |
Aclaris Therapeutics, Inc... |
Chief Legal Officer |
• – – |
2021-06-02 |
4 |
AS |
$21.50 |
$651,664 |
D/D |
(30,119) |
131,688 |
0 |
% |
|
64 Records found
|
|
Page 2 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
